These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 866309)

  • 1. [Condition of the liver in patients with chronic pulmonary tuberculosis receiving a combination of antibacterial drugs including rifampicin and ethambutol].
    Kondrat'eva VI; Umarova MK; Arifkhanova SI
    Probl Tuberk; 1977; (2):35-40. PubMed ID: 866309
    [No Abstract]   [Full Text] [Related]  

  • 2. [Liver function in patients with chronic destructive pulmonary tuberculosis during complex treatment with rifampicin and ethambutol].
    Kharakter ZhZ; Chertkova MA; Pavlenko AV
    Probl Tuberk; 1975; (10):44-8. PubMed ID: 1208440
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of ethambutol and rifampicin on sputum conversion in chronically infectious patients].
    Juchniewicz M; Radecki A; Kowalczyk H; Grzywacz W
    Gruzlica; 1974 May; 42(5):397-400. PubMed ID: 4464226
    [No Abstract]   [Full Text] [Related]  

  • 4. [Funtional status of the liver in patients with pulmonary tuberculosis treated with ethambutol and rifampicin].
    Priss IS
    G Ital Chemioter; 1972; 19(2):29-31. PubMed ID: 4666008
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tolerance of rifampicin and ethambutol and their effects on liver function during treatment of patients with destructive lung tuberculosis].
    Kalankhodzhaev AA; Stoianovskiĭ EA; Ginzburg VS
    Probl Tuberk; 1978 Mar; (3):19-23. PubMed ID: 652761
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of the use of rifampicin and ethambutol in complex treatment of chronic destructive pulmonary tuberculosis].
    Alimov ShA; Stoianovskiĭ EA
    Probl Tuberk; 1976; 3():27-31. PubMed ID: 967851
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].
    Masztalerz J
    Pneumonol Pol; 1976; 44(1):55-60. PubMed ID: 821043
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reactivation of pulmonary tuberculosis in patients treated with rifampicin and ethambutol].
    Kuznetsova ZA
    Probl Tuberk; 1985; (12):40-2. PubMed ID: 4095097
    [No Abstract]   [Full Text] [Related]  

  • 9. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rifampicin and ethambutol in treating chronic destructive pulmonary tuberculosis].
    Roslik SM; Iakovleva LM; Zhitnaia VI; Grushevskiĭ ES; Poluianova RP
    Probl Tuberk; 1980 Jun; (6):30-3. PubMed ID: 7393907
    [No Abstract]   [Full Text] [Related]  

  • 11. Rifampicin--ethambutol in retreatment of pulmonary tuberculosis.
    Mital OP; Narang RK; Sachan AS
    Indian J Chest Dis Allied Sci; 1976 Jul; 18(3):141-5. PubMed ID: 1026643
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effectiveness of treatment of patients with destructive forms of pulmonary tuberculosis with rifampicin and ethambutol].
    Mavrotskiĭ VV
    Klin Med (Mosk); 1974 Dec; 52(12):31-4. PubMed ID: 4444241
    [No Abstract]   [Full Text] [Related]  

  • 13. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
    Pines A; Raafat H; Siddiqui GM
    J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical significance of drug resistance of tuberculosis mycobacteria and L-forms].
    Golanov VS; Bogdalova VE; Andreev LP; Losin EI; Ushakova AG; Meshcheriakov VG; Bondin SV
    Probl Tuberk; 1991; (12):27-8. PubMed ID: 1803368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].
    Anastasatu C; Sibila S
    Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental in-vitro and in-vivo studies of the antibacterial effect of rifampicin and ethambutol].
    Kozulicyna TI; Korotajev GA
    G Ital Chemioter; 1972; 19(2):7-10. PubMed ID: 4199030
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative daily followed clinical study of treatment of chronic pulmonary tuberculosis with various combinations of ethambutol and rifampicin. Daily and intermittent method].
    Gruzlica; 1975 Dec; 43(12):1067-98. PubMed ID: 1193413
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of rifampin and ethambutol for the treatment of pulmonary tuberculosis].
    Shukiurov ShZ
    Probl Tuberk; 1973; 51(12):40-3. PubMed ID: 4782102
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness of rifampin and ethambutol in the treatment of pulmonary tuberculosis].
    Gol'dshteĭn VD; Prokhorov EP
    Probl Tuberk; 1973; 51(12):36-40. PubMed ID: 4782101
    [No Abstract]   [Full Text] [Related]  

  • 20. [Survival of tuberculous bacilli in combined treatments including rifampicin].
    Kreis B; Pretet S
    Rev Tuberc Pneumol (Paris); 1970; 34(3):429-33. PubMed ID: 4994940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.